Search

Your search keyword '"Cao, Jianli"' showing total 157 results

Search Constraints

Start Over You searched for: Author "Cao, Jianli" Remove constraint Author: "Cao, Jianli"
157 results on '"Cao, Jianli"'

Search Results

1. Author Correction: Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing

2. Identification of novel small-molecule inhibitors of SARS-CoV-2 by chemical genetics

4. Dip effect of stress transfer and structural instability mechanism of coal-rock combination

5. Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing

6. Targeting papain-like protease for broad-spectrum coronavirus inhibition

10. Control of SARS-CoV-2 infection by MT1-MMP-mediated shedding of ACE2

11. PMI-controlled mannose metabolism and glycosylation determines tissue tolerance and virus fitness

12. Clofazimine broadly inhibits coronaviruses including SARS-CoV-2

15. SARS-CoV-2 hijacks neutralizing dimeric IgA for nasal infection and injury in Syrian hamsters

16. A multimechanistic antibody targeting the receptor binding site potently cross-protects against influenza B viruses

21. Phosphatidic acid phosphatase 1 impairs SARS-CoV-2 replication by affecting the glycerophospholipid metabolism pathway

22. Experimental Investigation of the Influence for Stoping Sequence and Granular Grading on Lateral Pressure during the Nonpillar Sublevel Caving Mining

23. SARS-CoV-2 hijacks neutralizing dimeric IgA for enhanced nasal infection and injury

24. Low Environmental Temperature Exacerbates Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Golden Syrian Hamsters

26. Similarity Model Test on the Spatiotemporal Evolution Law of Deformation and Failure of Surrounding Rock-Induced Caving in Multi-Mined-Out Areas

27. Numerical Analysis for the Caving Characteristics of Rock Mass with Inclined Joints in Caving Mining

29. Inhaled Dry Powder Formulation of Tamibarotene, a Broad‐Spectrum Antiviral against Respiratory Viruses Including SARS‐CoV‐2 and Influenza Virus

32. Robust SARS-CoV-2 infection in nasal turbinates after treatment with systemic neutralizing antibodies

35. In silico structure-based discovery of a SARS-CoV-2 main protease inhibitor

36. Beneficial effect of combinational methylprednisolone and remdesivir in hamster model of SARS-CoV-2 infection

37. Viruses harness YxxØ motif to interact with host AP2M1 for replication: A vulnerable broad-spectrum antiviral target

38. Clofazimine is a broad-spectrum coronavirus inhibitor that antagonizes SARS-CoV-2 replication in primary human cell culture and hamsters

39. Discovery of the FDA-approved drugs bexarotene, cetilistat, diiodohydroxyquinoline, and abiraterone as potential COVID-19 treatments with a robust two-tier screening system

40. Metabolic Profiling Reveals Significant Perturbations of Intracellular Glucose Homeostasis in Enterovirus-Infected Cells

41. Broad-Spectrum Host-Based Antivirals Targeting the Interferon and Lipogenesis Pathways as Potential Treatment Options for the Pandemic Coronavirus Disease 2019 (COVID-19)

42. Surgical Mask Partition Reduces the Risk of Noncontact Transmission in a Golden Syrian Hamster Model for Coronavirus Disease 2019 (COVID-19)

44. A Large-scale Drug Repositioning Survey for SARS-CoV-2 Antivirals

45. Simulation of the Clinical and Pathological Manifestations of Coronavirus Disease 2019 (COVID-19) in a Golden Syrian Hamster Model: Implications for Disease Pathogenesis and Transmissibility

46. Robust SARS-CoV-2 Infection in Nasal Turbinate Despite Systemic Neutralizing Antibody

48. Prediction of the caved rock zones' scope induced by caving mining method

49. Screening of an FDA-Approved Drug Library with a Two-Tier System Identifies an Entry Inhibitor of Severe Fever with Thrombocytopenia Syndrome Virus

Catalog

Books, media, physical & digital resources